Skip to search formSkip to main contentSkip to account menu

Naltrexone

Known as: 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one, Naltrexonum, N-Cyclopropylmethylnoroxymorphone 
A noroxymorphone derivative with competitive opioid antagonistic property. Naltrexone reverses the effects of opioid analgesics by binding to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
To the Editor: Lithium, a first-line treatment for bipolar disorder, is a well-known cause of hypothyroidism; however, case… 
2010
2010
Despite high safety hurdles and a history of failure in the field, some drug firms remain cautiously optimistic for the next wave… 
1992
1992
To date, there are no clearly efficacious pharmacotherapies for alcoholism (Meyer, 1989). In a large multi–center controlled… 
1987
1987
Two patients with postconcussional syndrome whose most severe symptoms were blackouts, headaches, and amnesia episodes appeared… 
1986
1986
Thirty naltrexone and 30 methadone patients in outpatient opiate addiction treatment were compared on pretreatment psychosocial… 
1983
1983
Three narcotic antagonist drugs (EN-1639 or naltrexone, M-5050 or diprenorphine and the 6-oxo analogue of oxilorphan, S-20682… 
Review
1979
Review
1979
This paper reviews older results on EEG and behavioral effects of heroin and opiate antagonists in exaddicts, and presents new… 
1979
1979
Adult male Sprague Dawley rats were injected with low doses of the narcotic antagonist Naltrexone or vehicle and tested for motor… 
1976
1976
Abstinence signs were precipitated in rats by naloxone (1 mg - kg-1 s.c.) injected at various times (from 1.5 to 16 h) after a…